Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer

AUTOR(ES)

Alkarain, Angel

FONTE

BioMed Central

RESUMO

p27 is a key regulator of progression from G1 to S phase. Although the gene encoding p27 is rarely mutated in human cancers, p27 is functionally inactivated in a majority of human cancers through accelerated p27 proteolysis, through sequestration by cyclin D–cyclin-dependent kinase complexes and by cytoplasmic mislocalization. Here we review mechanisms whereby oncogenic activation of receptor tyrosine kinase and Ras pathways lead to accelerated p27 proteolysis and p27 mislocalization in cancer cells. The prognostic significance of p27 in human breast cancer is also reviewed.

Documentos Relacionados

• The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
• Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
• Expression and prognostic significance of lysozyme in male breast cancer
• Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E‐cadherin expression in gastric cancer
• ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR